151 related articles for article (PubMed ID: 20045676)
1. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.
Galeotti N; Vivoli E; Bilia AR; Vincieri FF; Ghelardini C
Biochem Pharmacol; 2010 May; 79(9):1327-36. PubMed ID: 20045676
[TBL] [Abstract][Full Text] [Related]
2. St. John's wort relieves pain in an animal model of migraine.
Galeotti N; Ghelardini C
Eur J Pain; 2013 Mar; 17(3):369-81. PubMed ID: 23152076
[TBL] [Abstract][Full Text] [Related]
3. St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes.
Galeotti N; Maidecchi A; Mattoli L; Burico M; Ghelardini C
Fitoterapia; 2014 Jan; 92():23-33. PubMed ID: 24125916
[TBL] [Abstract][Full Text] [Related]
4. Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.
Galeotti N; Ghelardini C
Psychopharmacology (Berl); 2013 May; 227(1):149-63. PubMed ID: 23254377
[TBL] [Abstract][Full Text] [Related]
5. A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of st John's Wort in mice.
Galeotti N; Vivoli E; Bilia AR; Bergonzi MC; Bartolini A; Ghelardini C
J Pain; 2010 Feb; 11(2):149-59. PubMed ID: 19945352
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
Galeotti N
J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
[TBL] [Abstract][Full Text] [Related]
7. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
8. PKC-mediated potentiation of morphine analgesia by St. John's Wort in rodents and humans.
Galeotti N; Farzad M; Bianchi E; Ghelardini C
J Pharmacol Sci; 2014; 124(4):409-17. PubMed ID: 24739262
[TBL] [Abstract][Full Text] [Related]
9. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
[TBL] [Abstract][Full Text] [Related]
10. St. John's wort reversal of meningeal nociception: a natural therapeutic perspective for migraine pain.
Galeotti N; Ghelardini C
Phytomedicine; 2013 Jul; 20(10):930-8. PubMed ID: 23578992
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids of St. John's Wort reduce HPA axis function in the rat.
Butterweck V; Hegger M; Winterhoff H
Planta Med; 2004 Oct; 70(10):1008-11. PubMed ID: 15490333
[TBL] [Abstract][Full Text] [Related]
12. Effect of St. John's Wort standardized extract and hypericin on in vitro placental calcium transport.
da Conceição AO; Takser L; Lafond J
J Med Food; 2010 Aug; 13(4):934-42. PubMed ID: 20553141
[TBL] [Abstract][Full Text] [Related]
13. St. John's Wort Potentiates anti-Nociceptive Effects of Morphine in Mice Models of Neuropathic Pain.
Sanna MD; Ghelardini C; Galeotti N
Pain Med; 2017 Jul; 18(7):1334-1343. PubMed ID: 27688309
[TBL] [Abstract][Full Text] [Related]
14. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
15. Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice.
Grundmann O; Kelber O; Butterweck V
Planta Med; 2006 Dec; 72(15):1366-71. PubMed ID: 17051457
[TBL] [Abstract][Full Text] [Related]
16. Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway.
Chang Y; Wang SJ
Eur J Pharmacol; 2010 May; 634(1-3):53-61. PubMed ID: 20193678
[TBL] [Abstract][Full Text] [Related]
17. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
Beattie PE; Dawe RS; Traynor NJ; Woods JA; Ferguson J; Ibbotson SH
Br J Dermatol; 2005 Dec; 153(6):1187-91. PubMed ID: 16307656
[TBL] [Abstract][Full Text] [Related]
18. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
[TBL] [Abstract][Full Text] [Related]
19. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect.
Hatanaka J; Shinme Y; Kuriyama K; Uchida A; Kou K; Uchida S; Yamada S; Onoue S
Drug Metab Pharmacokinet; 2011; 26(6):551-8. PubMed ID: 21914965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
